Literature DB >> 11076510

An additional H-bond in the alpha 1 beta 2 interface as the structural basis for the low oxygen affinity and high cooperativity of a novel recombinant hemoglobin (beta L105W).

T Y Fang1, V Simplaceanu, C H Tsai, N T Ho, C Ho.   

Abstract

Site-directed mutagenesis has been used to construct three recombinant mutant hemoglobins (rHbs), rHb(beta L105W), rHb(alpha D94A/betaL105W), and rHb(alpha D94A). rHb(beta L105W) is designed to form a new hydrogen bond from beta 105Trp to alpha 94Asp in the alpha(1)beta(2) subunit interface to lower the oxygen binding affinity by stabilizing the deoxy quaternary structure. We have found that rHb(beta L105W) does indeed possess a very low oxygen affinity and maintains normal cooperativity (P(50) = 28.2 mmHg, n(max) = 2.6 in 0.1 M sodium phosphate at pH 7.4) compared to those of Hb A (P(50) = 9.9 mmHg, n(max) = 3.2 at pH 7.4). rHb(alpha D94A/beta L105W) and rHb(alpha D94A) are expressed to provide evidence that rHb(betaL 105W) does form a new H-bond from beta 105Trp to alpha 94Asp in the alpha(1)beta(2) subunit interface of the deoxy quaternary structure. Our multinuclear, multidimensional nuclear magnetic resonance (NMR) studies on (15)N-labeled rHb(beta L105W) have identified the indole nitrogen-attached (1)H resonance of beta 105Trp for rHb(beta L105W). (1)H NMR studies on Hb A and mutant rHbs have been used to investigate the structural basis for the low O(2) affinity of rHb(beta L105W). Our NMR results provide evidence that rHb(beta L105W) forms a new H-bond from beta 105Trp to alpha 94Asp in the alpha(1)beta(2) subunit interface of the deoxy quaternary structure. The NMR results also show that these three rHbs can switch from the R quaternary structure to the T quaternary structure in their ligated state upon addition of an allosteric effector, inositol hexaphosphate. We propose that the low O(2) affinity of rHb(beta L105W) is due to the formation of a new H-bond between alpha 105Trp and alpha 94Asp in the deoxy quaternary structure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076510     DOI: 10.1021/bi001115i

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Sickle Cell Hemoglobin with Mutation at αHis-50 Has Improved Solubility.

Authors:  Ming F Tam; Tsuey Chyi S Tam; Virgil Simplaceanu; Nancy T Ho; Ming Zou; Chien Ho
Journal:  J Biol Chem       Date:  2015-07-16       Impact factor: 5.157

2.  Structure-function relationship in a variant hemoglobin: a combined computational-experimental approach.

Authors:  Matteo Ceccarelli; Paolo Ruggerone; Roberto Anedda; Antonella Fais; Benedetta Era; Maria Carla Sollaino; Marcella Corda; Mariano Casu
Journal:  Biophys J       Date:  2006-07-14       Impact factor: 4.033

3.  Interfacial and distal-heme pocket mutations exhibit additive effects on the structure and function of hemoglobin.

Authors:  David H Maillett; Virgil Simplaceanu; Tong-Jian Shen; Nancy T Ho; John S Olson; Chien Ho
Journal:  Biochemistry       Date:  2008-09-13       Impact factor: 3.162

4.  Autoxidation and oxygen binding properties of recombinant hemoglobins with substitutions at the αVal-62 or βVal-67 position of the distal heme pocket.

Authors:  Ming F Tam; Natalie W Rice; David H Maillett; Virgil Simplaceanu; Nancy T Ho; Tsuey Chyi S Tam; Tong-Jian Shen; Chien Ho
Journal:  J Biol Chem       Date:  2013-07-18       Impact factor: 5.157

5.  Role of β/δ101Gln in regulating the effect of temperature and allosteric effectors on oxygen affinity in woolly mammoth hemoglobin.

Authors:  Yue Yuan; Catherine Byrd; Tong-Jian Shen; Virgil Simplaceanu; Tsuey Chyi S Tam; Chien Ho
Journal:  Biochemistry       Date:  2013-11-21       Impact factor: 3.162

6.  Structural and Functional Characterization of a New Double Variant Haemoglobin (HbG-Philadelphia/Duarte α(2)β(2)).

Authors:  Antonella Fais; Mariano Casu; Paolo Ruggerone; Matteo Ceccarelli; Simona Porcu; Benedetta Era; Roberto Anedda; Maria Carla Sollaino; Renzo Galanello; Marcella Corda
Journal:  ISRN Hematol       Date:  2010-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.